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Evaluation of MR/Fluoroscopy–guided
Portosystemic Shunt Creation in a Swine Model
Aravind Arepally, MD, Parag V. Karmarkar, MS, Di Qian, MS, Brad Barnett, BS, and Ergin Atalar, PhD
PURPOSE: To evaluate three different percutaneous portosystemic shunts created with magnetic resonance (MR)
imaging and fluoroscopy guidance in a swine model.
MATERIALS AND METHODS: In stage 1 of the experiment, an active MR intravascular needle system was created
for needle tracking and extracaval punctures. Twenty inferior vena cava (IVC)/superior mesenteric vein (SMV)/portal
vein (PV) punctures were performed in 10 swine (weight, 40–45 kg) in a 1.5-T short-bore interventional MR imager.
With use of a real-time MR imaging sequence, the needle was guided through the IVC and into the SMV or PV (N 
20 punctures). After confirmation, a wire was advanced into the portal venous system under MR imaging guidance
(N  20). In stage 2, animals were transferred to the radiographic fluoroscopy suite for deployment of shunts. Three
different shunts were evaluated in this study: (i) a commercial stent-graft, (ii) a prototype bridging stent, and (iii) a
prototype nitinol vascular anastomotic device. Postprocedural necropsy was performed in all animals.
RESULTS: Successful MR-guided IVC/SMV punctures were performed in all 20 procedures (100%). All three shunts
were deployed. Stent-grafts had the poorest mechanism for securing a shunt. The vascular anastomotic device and the
bridging stent had more secure anchoring mechanisms but also had higher technical failure rates (50% and 40%,
respectively). When deployed successfully, the vascular anastomotic device resulted in no bleeding at the sites of
punctures at necropsy.
CONCLUSION: Percutaneous shunts and vascular anastomoses between the portal mesenteric venous system and
IVC were successfully created with use of a combination of MR imaging and conventional fluoroscopy for guidance.
J Vasc Interv Radiol 2006; 17:1165–1173
Abbreviations: IVC  inferior vena cava, PV  portal vein, SMV  superior mesenteric vein, TIPS  transjugular intrahepatic portosystemic shunt
DESPITE advances in medical and
surgical therapies, the management of
portal hypertension remains a chal-
lenge. Current options include surgi-
cal creation of a portosystemic shunt,
liver transplantation, and creation of a
transjugular intrahepatic portosys-
temic shunt (TIPS) (1). As a result of
the limited availability of donor livers
and technical surgical expertise, trans-
plantation is not a viable option for the
majority of candidates (2).
Surgical portosystemic shunts have
traditionally been accomplished with
(i) a surgical end-to-side mesocaval
shunt that decompresses the portal
vein (PV) or (ii) a side-to-side spleno-
renal shunt to decompress the splenic
vein (3,4). Because the creation of
these shunts is selective, a significant
portion of portal venous flow is main-
tained, and these shunts are therefore
associated with a low rate of enceph-
alopathy and recurrent bleeding (5).
However, these surgical procedures
have also been associated with high
complication rates. Particularly in pa-
tients with extensive retroperitoneal
collateral vessels, surgical interven-
tions can be difficult, and periopera-
tive mortality rates of 20%–50% have
been noted (6). By contrast, creation of
a TIPS is associated with higher inci-
dences of encephalopathy, recurrent
bleeding, and shunt occlusion (4) com-
pared with surgical shunts. In addi-
tion, because the procedure is per-
formed without direct visualization of
the portal venous system, potential
complications include traversal of the
liver capsule and creation of fistulous
tracts from the shunt to the hepatic
artery or bile ducts (7). However, the
percutaneous creation of a portomes-
enteric/caval shunt may provide the
maximum advantage of a selective
shunt with the benefit of lower com-
plication rates.
The goals of this study were to
demonstrate the feasibility of creating
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a percutaneous extrahepatic por-
tomesenteric shunt under guidance by
magnetic resonance (MR) imaging/
conventional fluoroscopy and to as-
sess the three types of shunts created.
MATERIALS AND METHODS
Animal Model
The institutional animal care and
use committee approved the animal
studies. We performed experiments
on 10 healthy swine (weight, 40–45
kg). Sedation was achieved with xyla-
zine and ketamine. After endotracheal
intubation, inhaled isoflurane (2%)
was provided during mechanical ven-
tilation with oxygen (98%). Percutane-
ous access into the right femoral vein
was achieved under ultrasound (US)
guidance, followed by placement of a
12-F sheath into the femoral vein. All
animals were transferred to the MR
suite for the remaining portion of the
procedure.
Needle Design
The needle design of the active MR
needle, the prototype of which was
developed in our laboratory (by P.K.
and E.A.), has been previously de-
scribed (8). This needle is made of two
concentrically configured pieces of
nitinol tubing that are insulated from
each other, with the inner tubing ex-
tending 4 cm beyond the outer tubing
to form a loopless antenna (9). The
intravascular needle antenna has a
central lumen that can accommodate a
0.038-inch guide wire, and therefore
the antenna can be safely advanced
over the wire through a femoral vein
approach. The needle system is 9 F in
caliber with a sharpened three-face
bevel at the distal end. To facilitate
puncture, the shaft is preshaped at the
distal tip to provide a 55° angle for all
vascular punctures. The inner lumen
of the inner tube is further insulated
with a liner that electrically isolates
the system and acts as a guide wire
lumen (0.038-inch wire compatible).
The entire assembly is insulated with
nylon to isolate the needle compo-
nents from direct electrical contact
with biologic fluids except at the distal
tip of the needle. The radiofrequency
circuitry matches the transmission at
63.86 MHz to enable active visualiza-
tion of the needle (10) (Figs 1, 2). To
perform transvascular punctures, the
distal tip of the needle is oriented in
the direction of the puncture. A sec-
ond standard nitinol guide wire (ev3,
Plymouth, MN) has been modified so
that the tip (0.035 inches) is sharpened
and is advanced 1 cm outside the ac-
tive needle to facilitate the puncture.
Shunt Design
One commercial shunt (shunt A)
and two custom-manufactured shunts
(shunts B and C) shunts were evalu-
ated in the study.
Shunt A.—Shunt A was a commer-
cially available covered stent-graft
(Viabahn; W.L. Gore & Associates,
Flagstaff, AZ). This stent-graft is a
flexible, self-expanding stent that
consists of an expanded polytetra-
fluoroethylene lining with an exter-
nal nitinol support extending along
the entire length. The stent-graft is
attached to a dual-lumen polyethyl-
ene delivery catheter, and the device
used in this study had a working
length of 75 cm. The delivery cathe-
ter is attached to a three-port clear
plastic adapter (ie, hub assembly)
that includes a central port for guide
wire introduction, a second port for
system flushing, and a third port for
the deployment system. Five differ-
ent stent grafts (8 mm in diameter, n
 2; 10 mm in diameter and 6 cm in
length, n  3) were used for this
study.
Shunt B.—Shunt B (Fig 3) was con-
structed in our laboratory and was
Figure 1. Conventional MR angiography/venography of the mesenteric venous system
performed with 30 mL of gadolinium diethylenetriamine pentaacetic acid (4.8-msec
repetition time; 1.4-msec echo time; 25º flip angle; 256  256 image matrix) before any
punctures. White arrow indicates active needle; black arrow indicates PV.
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designed to serve as a bridging stent
between the two vascular beds. The
centerpiece of the shunt device was
made of a section of a nitinol stent
1 cm in diameter and 1 cm long.
Three nitinol anchoring struts were
vertically attached symmetrically
around the stent body with 120° of
radial distance from each other. Each
end of the nitinol strut had a 1-cm-
long flange protruding outward from
the stent. These flanges provided an
anchoring force for the shunt device
so that when the device was de-
ployed, the flanges on each end
hooked onto the inner wall of each
vessel and locked the two vessels to-
gether. The bridging stent was de-
ployed with use of a stent delivery
catheter, which deployed the bridg-
ing stent in two stages. To create the
shunt, the distal anchors of this de-
vice were first deployed in the por-
tal/mesenteric system. The deployed
anchors were then used to pull the
portal/mesenteric veins closer to the
IVC so that the proximal anchors in
the IVC could be released and de-
ployed.
Shunt C.— Shunt C (Fig 4) was con-
structed in our laboratory and was
designed to serve as an anastomosis
between the two vascular beds. The
anastomotic device was made of a sin-
gle piece of 0.009-inch nitinol shape-
memory wire (NDC, Fremont, CA).
The nitinol wire was bent into a fixed
shape and mounted on a stainless-steel
frame. This preshaped nitinol wire was
then placed inside a high-power elec-
trical furnace and heated for 20 min-
utes at 550ºC. The nitinol wire would
then maintain this shape at room tem-
perature. The shape of the anastomotic
device was a short-bore ring with two
sets of flanges on each side. The di-
ameter of the ring was approximately
1 cm when fully relaxed, and the
length was approximately 3 mm.
There were six flanges on each side
of the ring, and the flange was 5 mm
long. The flanges were placed sym-
metrically around the ring with a ra-
dial distance of 30° from each other.
The anastomotic device was placed
in the same way as the shunt device
inside a delivery catheter and was
deployed with the same technique.
The shortened device body held the
two vessels close to each other and
therefore minimized blood leakage
from the vessels.
Technique
Creation of percutaneous portosys-
temic shunts was performed with use
of interventional MR imaging (stage 1)
and conventional fluoroscopy (stage
2).
Stage 1: MR-guided access to portal-
mesenteric venous system.—Thirteen
IVC/superior mesenteric vein (SMV)/
PV punctures were performed in 10
swine in a 1.5-T short-bore interven-
tional MR scanner (CV/i; GE Medi-
cal Systems, Milwaukee, WI). Images
were acquired by a combination of
external phased-array coils and an
intravascular needle. The needle was
introduced from the common femo-
Figure 2. (a) MR-guided puncture and catheterization of the mesenteric venous circulation performed with real-time gradient-recalled
echo sequence (3.4-msec repetition time; 1.2-msec echo time; 45º flip angle; 30-cm field of view; 6–8 frames/sec) in combination with
an interactive scan plane acquisition. Short arrow indicates PV; long arrow indicates IVC. (b) Conventional venogram of PV (short
arrow) and IVC (long arrow) before deployment of shunts.
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Figure 3. (a,b) Lateral and anterior views of shunt
B. The centerpiece of the shunt device is made from
a section of a nitinol stent 1 cm in diameter and
1 cm long. Three nitinol anchoring struts are verti-
cally attached symmetrically around the stent body,
with 120° of radial distance from each other. Each
end of the nitinol strut has a 1-cm-long flange pro-
truding outward from the stent. (c) Venogram after
deployment of shunt B (white arrowheads) from the
PV (short white arrow) to the IVC (black arrow).
There is no evidence of extravasation at angiogra-
phy. (d) At necropsy, shunt (white arrowheads) is
intact and bridges both vascular beds. Long black
arrow indicates PV; black arrowhead indicates IVC.
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ral vein through a standard 12-F vas-
cular sheath and advanced over a
0.035-inch nitinol guide wire (ev3).
All procedures were performed by
an experienced interventional radiolo-
gist. During the procedure, the inter-
ventionalist advanced the needle with
use of an imaging console adjacent to
the MR imaging scanner to monitor
needle tracking and orientation. A
separate person controlled the imag-
ing parameters and slice orientation
based on the feedback of the interven-
tionalist. The needle was positioned in
the IVC and rotated to the correct ori-
entation according to a real-time gra-
dient-recalled echo sequence. The nee-
dle was readily tracked at all times, and
multiple projections were used to con-
firm the needle position throughout the
procedure. After the needle was intro-
duced and before performance of any
puncture, MR angiography/venogra-
phy of the mesenteric venous system
(Fig 1) was performed with 30 mL of
gadolinium diethylenetriamine penta-
acetic acid (4.8-msec repetition time; 1.4-
msec echo time; 25º flip angle; 31.2-kHz
bandwidth; field of view, 256  256
image matrix).
With a real-time gradient-recalled
echo sequence (3.4-msec repetition
time; 1.2-msec echo time; 45º flip an-
gle; 30-cm field of view; 6–8 frames/
sec), in combination with an interac-
tive scan plane acquisition (i-Drive;
GE Medical Systems), the needle was
advanced into the IVC and guided to
the level where the SMV was closest to
the IVC (Fig 3a, b). After proper ori-
entation of the active needle toward
the target vessel, the path of the needle
was examined to confirm that no ves-
sels or retroperitoneal structures
would be inadvertently injured. Next,
a second standard nitinol guide wire
with a sharpened tip (ev3) was coaxi-
ally introduced. The sharpened tip
was advanced 1 cm outside the active
needle to facilitate the puncture; pas-
sive tracking of the sharpened tip was
used to monitor the progress of the
needle as it exited the IVC and entered
the SMV. Under a real-time gradient-
recalled echo sequence with multipla-
nar views, the entire system (ie, sharp-
ened needle and active needle) was
advanced as a unit until the PV/SMV
was entered. After removal of the
sharpened guide wire, immediate re-
turn of blood through the active nee-
dle confirmed that the SMV had been
successfully punctured. After removal
of the guide wire, a direct MR porto-
gram was obtained through the needle
with use of 10 mL of gadolinium di-
Figure 4. (a) Frontal and lateral view of shunt C (anastomotic
device). (b,c) Distal anchors are deployed into the portal/mes-
enteric circulation, which are used to then pull the vein back
until the proximal anchors can be deployed in the IVC (d). (e)
Conventional angiogram obtained through anastomosis after
deployment of device shows close apposition of PV to IVC. (f)
Direct inspection of anastomosis after deployment of device.
There is complete apposition (short interrupted arrow) of the
portal/mesenteric venous system (short arrowhead) to the IVC
(long white arrow).
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ethylenetriamine pentaacetic acid at a
concentration of 25% (fast spoiled gra-
dient echo sequence; 6-msec repetition
time; 1.3-msec echo time; 90º flip an-
gle; no slice selection; excitations, 0.5;
45-cm  22.5-cm field of view; 3
frames/sec). In three animals (when
allotted MR imaging time allowed),
two separate punctures were made.
After confirmation, a wire (018 inches
or 0.035 inches) was advanced into the
portal venous system under MR imag-
ing guidance (n  13) (Fig 2).
Stage 2: creation of portal/mesocaval
shunt.—After successful access into the
portomesenteric venous circulation, an-
imals were transferred to a conven-
tional fluoroscopic suite for deploy-
ment of shunts. Under fluoroscopic vi-
sualization, the puncture needle was
removed and angioplasty of the retro-
peritoneum was performed with a
6-mm  4-cm balloon (Cordis, Miami,
FL). After angioplasty, devices were
then advanced to create the shunt.
Shunt A was deployed in a stan-
dard fashion as described by the man-
ufacturer. To launch shunts B and C,
a device-deploying catheter was de-
signed specifically for this purpose,
similar to the commercial sheath-
based delivery systems used for self-
expanding stents. The delivery system
was compatible with a 10-F, 0.038-
inch wire. The delivery system was
made of two components, the inner
tubing assembly and the outer deliv-
ery sheath. Shunts A and B were col-
lapsed between the two and then re-
leased in stages by gradually pulling
back on the sheath. The inner member
was made of a nylon tube 80 cm long
with a 0.038-inch wire–compatible
central lumen. The proximal 76 cm of
the tube was stiffened by the addition
of a concentric stiff polyamide tube
over the nylon tube. At the proximal
end of the tube was a connector/hub,
and at the distal end of the inner
member was a cone-shaped nylon
component to enable gradual ad-
vancement of the device into the PV
through the vascular puncture. A stent
pusher, which was a 3-mm-diameter
tube, was glued 2 cm from the proxi-
mal end of the distal cone. The inner
member was advanced in a 70-cm 10-F
sheath (Fast Cath sheath; St. Jude
Medical, Minnetonka, MN). The shunts
(A and B) were collapsed on the inner
member between the proximal end of
the distal cone and the distal end of
the stent pusher. This delivery system
enabled easy advancement from one
vessel to another as the device entered
the punctured opening of the PV, as
well as the ability to deliver the shunts
in two stages. When the shunt device
was deployed, the distal tip of the de-
livery catheter first entered the PV.
Withdrawing the outer sheath by 1 cm
released the distal anchoring flanges/ver-
tical struts of the shunt device. With the
flanges hooked to the inner wall of the
PV, the physician could pull the vessel
toward the IVC. Therefore, as the proxi-
mal section of the shunt device reentered
the IVC, the outer sheath was then further
withdrawn to release the second set of
flanges, which locked onto the inner wall
of the IVC. In this fashion, the shunt de-
vice was completely deployed; the nitinol
stent tubing at the center would open and
allow blood flow from the IVC to the PV.
After deployment of all shunts,
catheter-based angiography was per-
formed with a multiple–side hole
straight catheter (Cook, Bloomington,
IN) to assess the anastomosis for leak-
age and positioning of the grafts. Post-
procedural necropsy was performed
in all animals to assess for bleeding,
and direct inspection of the anchoring
mechanism of all shunts was per-
formed.
Data Analysis
For stage 1 of the experiment, tech-
nical success for transcaval puncture
was defined as traversal of the needle
from the IVC to the SMV or PV with-
out traversal of any retroperitoneal or-
gans. In addition to success rates, the
number of passes required for each
successful procedure was noted. For
stage 2 of the experiment, technical
success for MR-guided shunt creation
was based on angiography and direct
inspection of each shunt. This was de-
fined by the ability to bridge the two
vascular beds with the shunt without
traversing any organs. In addition, the
stability of the anchoring mechanism
of each shunt was assessed. When
there was a successful creation of a
shunt, bleeding at the site of the shunt
was classified as (i) major if diffuse
hemorrhage was present in the perito-
neal cavity, (ii) moderate if bleeding
and hemorrhage was localized to the
shunt, or (iii) none if bleeding or he-
matoma could not be identified at the
site of the shunt.
RESULTS
Stage 1: MR-guided Access to
Portal-mesenteric Venous System
Successful MR-guided IVC/SMV/
PV punctures were performed in all
13 procedures (100%). All procedures
were performed with real-time MR
imaging sequences with use of free-
breathing techniques and without elec-
trocardiographic gating. Punctures were
made with no change in cardiac rhythm
or rate and with no sequelae. As a re-
sult of the mobility of the SMV and PV,
real-time imaging was necessary in all
punctures to reorient the needle to-
ward the target vessel. During real-time
gradient-recalled echo sequences, 4–8
frames/sec were possible throughout
the procedure. Active tracking of the
needle as it traversed the IVC toward
the SMV/PV was possible. All proce-
dures were successful (100%), with di-
rect puncture of the SMV (n  5) or PV
(n  8) and no traversal of any retro-
peritoneal organs/vessels. In 12 of 13
animals, punctures were made with
one pass. One procedure took two
passes to access the PV. On the basis of
imaging and direct visualization, all
punctures went directly into the target
vessels without traversal of any retro-
peritoneal organs/vessels (Figs 1, 2).
Stage 2: Creation of
Portal/Mesocaval Shunt
Shunt A.—With shunt A, the tech-
nical success rate was 100% with
stent-grafts. However, on direct in-
spection, these stents also had the
poorest mechanism for securing a
shunt. Because of the trajectory of the
needle punctures, the stents were un-
able to expand against the vascular
lumen to create a stable shunt be-
tween the two vascular beds. As a
result of this poor anchoring mecha-
nism, a major amount of bleeding
was noted around the shunt.
Shunt B.—With shunt B, the tech-
nical success rate was 60% (three of
five cases). Failures were caused by
malpositioning of the proximal an-
chors, which resulted in deployment
into the retroperitoneum and not in
the IVC. As a result of poor visibility
of the anterior wall of the IVC, pre-
cise placement of the proximal an-
chors in the IVC was difficult. When
the shunt was placed correctly, a
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moderate amount of bleeding around
the shunt was noted in two of three
swine. Angiography showed no leak-
age into the retroperitoneum.
Shunt C.—With shunt C, the vas-
cular anastomotic device had the
highest technical failure rate (50%)
but also had the most secure anchor-
ing mechanism. The vascular anasto-
motic device allowed very close ap-
position of the vascular beds so any
potential space was eliminated be-
tween the vascular lumens. There
was no bleeding at the sites of the
punctures at necropsy.
DISCUSSION
The creation of a percutaneous ex-
trahepatic portosystemic shunt is con-
tingent on two critical steps: (i) safe
and dependable extrahepatic trans-
caval punctures into the portal cir-
culation and (ii) a reliable conduit
that will enable shunting into the sys-
temic circulation. We demonstrated
that with the use of multiplanar real-
time MR imaging and conventional
fluoroscopy, a percutaneous extrahe-
patic portosystemic shunt and an
anastomosis can be constructed in a
staged fashion. Under complete MR
guidance, we were able to perform
methodical and targeted access into
the mesenteric/portal system. In addi-
tion, using this access, we were then
able not only to create a conventional
extrahepatic portosystemic shunt but
also to then create a percutaneous
anastomosis between the vessels.
Extrahepatic Puncture of the
Portomesenteric Venous System
Because of the anatomic isolation of
the mesenteric venous system, various
authors have described percutaneous
extrahepatic portal system shunt pro-
cedures (11–14). One limiting step in
the evolution of this procedure has
been a reliable technique to target and
puncture the portal/mesenteric veins
percutaneously. Initial attempts used
fluoroscopy and dual catheters in the
PV and IVC for complex fluoroscopic
angulations and punctures. Kaminou
et al (11) first described the use of this
technique to puncture the splenic vein
from the IVC. In a swine model, the
PV was directly punctured, followed
by placement of a wire basket into the
splenic vein to serve as a target for the
punctures. This procedure was suc-
cessful in four of five swine in creating
a shunt. However, in all four success-
ful punctures, necropsy demonstrated
that the needle and stent were placed
through the pancreas. In addition to
being fairly cumbersome, the inability
to visualize retroperitoneal structures
limited the utility of this technique.
In a study by Vivas et al (12), cre-
ation of an extrahepatic portacaval
shunt in a canine model was per-
formed with use of the jejunal veins
from the mesentery that were exposed
after a laparotomy. After placement of
another catheter in the IVC, a blind
puncture was made from the PV into
the IVC. With this access, a covered
prosthesis was placed to simulate a
portacaval shunt. However, because of
the lack of visibility, six of 10 animals
died after the procedure as a result of
major retroperitoneal bleeding caused
by multiple vascular punctures. Both
these studies further reinforce the im-
portance of visualization of the retro-
peritoneum during these invasive pro-
cedures.
More recent developments have
used adjunctive imaging to facilitate
safe punctures. In studies performed
by Wallace et al (13,14), intravascular
US was used for real-time image guid-
ance. This allowed for a mean of 1.75
needle passes (range, 1–4) to enter the
PV. However, intravascular US pro-
vides limited single axial plane imag-
ing, and the target vein must be very
close to the IVC for complete visual-
ization to facilitate safe needle pas-
sage. These inherent limitations re-
strict the vasculature available for
effective shunting to target vessels that
are adjacent to the IVC.
During the past decade, MR guid-
ance has been investigated as an alter-
nate guidance modality for interven-
tional procedures. In addition to high
spatial resolution, MR imaging can
provide real-time multiplanar imaging
of the vascular system. In addition, the
lack of ionizing radiation and/or io-
dinated contrast medium makes this
an inviting modality for image-guided
procedures. Kee et al (15,16) initially
described the use of MR imaging to
replicate a TIPS procedure in an MR
suite in animal and clinical studies. By
use of a hybrid radiography/MR im-
aging suite and a modified nitinol
TIPS needle set, MR-guided punctures
into the intrahepatic PV were per-
formed to replicate a TIPS procedure.
For all the studies (16), the susceptibil-
ity artifact of the needle system was
used to track the advancement and
punctures (ie, passive tracking). How-
ever, passive tracking can be imprecise
as a result of distortion of the imaging
field and can be inaccurate in locating
the catheter or needle.
As previously described, we have
developed a completely active (ie, vis-
ible) needle that can be used for vari-
ous endovascular interventions in the
MR imaging suite (16). Unlike passive
tracking, active tracking allows for
precise localization and full visualiza-
tion from the needle tip through the
entire shaft. With the dual capability
of real-time MR imaging and an active
transvascular needle, we were able to
take advantage of the three-dimen-
sional anatomic vascular imaging pro-
vided by MR imaging to precisely
monitor the needle throughout the en-
tire puncture. With this dual capabil-
ity, we could then evaluate the entire
systemic, mesenteric, and portal circu-
lation with standard MR angiographic
imaging. This provided a roadmap for
determining the optimal sites for IVC
puncture and for entering the portal/
mesenteric circulation. In addition, in
a real-time setting, we were able to
calculate the angle between the target
planes, the distance between the two
vessels, and any displacement of the
target vein during the punctures. Fi-
nally, the field of view could be
readily adapted to monitor adjacent
organs and vital vessels in a real-time
setting. Because of these technical im-
provements, we believe MR guidance
with an active transvascular needle is
a safe and reliable technique for this
stage of the procedure.
Percutaneous Extrahepatic
Portosystemic Shunts
For clinical implementation, not
only are safe and reliable transvascu-
lar punctures required, but an effec-
tive and stable shunt must be con-
structed between the two circulatory
beds. The standard surgical mesocaval
shunt is created by constructing a con-
duit between the SMV and the IVC (5).
By contrast, a splenorenal shunt is
simply constructed by creation of an
anastomosis between the two veins
(17).
The ideal percutaneous shunt would
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be able to simulate a surgical anasto-
mosis. However, to our knowledge, no
studies to date have been able to con-
struct such a shunt; in fact, all previous
animal studies have replicated surgical
shunts by deploying a variety of percu-
taneous bridging stents to construct an
extrahepatic portacaval shunt. Peterson
et al (18) initially described the creation
of a portacaval shunt with polytetra-
fluoroethylene-covered stent-grafts in
an animal study and a very limited clin-
ical trial. However, these studies in-
volved only intrahepatic shunts that
were similar to TIPS as a result of the
intrahepatic location of the shunt. Wal-
lace et al (13,14) demonstrated an extra-
hepatic shunt in a feasibility and sur-
vival animal model using intravascular
US and a flanged stent-graft. The initial
feasibility study with their prototype
design demonstrated that this type of
shunt could be created, but the shunt
had very poor patency, with near-com-
plete occlusion of all stent-grafts placed.
A study with longer follow-up (13),
which used a newer stent design and
adjunctive embolization of the PV to
simulate portal hypertension, showed
some improvement in patency, but five
of six animals had 50%–100% narrow-
ing at 12-week follow-up. Finally, a re-
cent study by Niyyati et al (19) de-
scribed the use of intravascular US and
a self-expanding stent with a submuco-
sal covering to create a portacaval shunt.
In findings similar to those of Wallace et
al (13,14), nearly all the animals had se-
vere stenosis or rapid occlusion as a re-
sult of neointimal hyperplasia.
Despite the technical feasibility of
these procedures, enthusiasm has
been dampened, largely because of
poor patency rates. This is primarily a
result of the accelerated development
of intimal hyperplasia seen with stent
or stent-graft placement in the venous
circulatory system. To improve pa-
tency, the hyperplasia should be ad-
dressed with some form of adjunctive
pharmacologic therapy or by minimiz-
ing the physical length and dimen-
sions of the shunts. In their feasibility
study of portacaval shunts, Seong et al
(20) commented that an ideal system
would be a short stent-graft with a
nitinol frame and a horizontal course
with the capability to bring the veins
together. Therefore, attempts to create
a surgical anastomosis may provide
the optimal alternative.
In our study, we have demon-
strated that a variety of extrahepatic
PV-to-IVC shunts can be created un-
der guidance by MR imaging. We
were able to construct these shunts
from a commercially available stent-
graft (shunt A) and a bridging nitinol
stent (shunt B), and also to create a
shunt with a vascular anastomosis
(shunt C). Shunts A and B, which had
very poor patency at follow-up, were
similar in design to those used in ear-
lier animal studies performed by sev-
eral authors. Although the anchoring
mechanism in shunt B was more se-
cure, it was inherently limited by the
stent design, which has been shown to
cause shunt thrombosis and intimal
hyperplasia. However, in comparing
the three shunts that were constructed,
shunt C is the design that merits fur-
ther exploration. Although shunt C (ie,
the anastomotic device) was associ-
ated with the highest technical failure
rate (50%), it also had the most secure
anchoring mechanism. The vascular
anastomotic device allowed very close
apposition of the vascular beds so that
any potential space was eliminated be-
tween the vascular lumens. This re-
sulted in almost no bleeding at the
sites of the punctures and demon-
strated a complete vascular seal at nec-
ropsy.
MR guidance also allowed for full
evaluation of the venous circulatory
bed and the ability to create a trajec-
tory into a desired vein that would be
appropriate for anastomosis. In fact, as
a result of the needle trajectory course,
the stability of shunt A was weak, be-
cause the stents were unable to ex-
pand sufficiently against the vascular
lumen. However, because of the hori-
zontal course of the needle, the anas-
tomosis device, which is composed of
nitinol, was capable of pulling the tar-
get vein close to the IVC to create a
vascular seal. When correctly de-
ployed, the anastomosis allowed for
very close apposition of the vascular
beds. This provided the optimal shunt
because any potential space was elim-
inated between the vascular lumens
and there was no bleeding at the sites
of punctures. In addition, because
minimal nitinol material was left
across the vascular lumens, this could
minimize turbulence, which could af-
fect patency rates. We also noted that,
when the anastomosis is constructed
safely, this was associated with almost
no bleeding as well as a stable and
secure seal between the two vascular
beds.
Our main limitation in this study
was the reliable construction of the
anastomosis. Because of inherent
problems with conventional fluoros-
copy, there was poor visualization of
the anterior IVC wall, which resulted
in imprecise placement of the proxi-
mal phalanges of the anastomosis de-
vice. To address this problem, a poten-
tial solution will be to construct the
entire anastomosis in an MR environ-
ment in which both vascular lumens
can be monitored during deployment.
Finally, these types of anastomoses
may create new difficulties not previ-
ously seen with procedures such as
TIPS. This includes stability of the
anastomoses, potential for stricture
formation, and formation of pseudoa-
neurysms. All these concerns will
have to be addressed in long-term lon-
gitudinal studies.
CONCLUSIONS
Transcaval punctures to the portal-
mesenteric venous system are feasible
with MR imaging guidance. Using a
combination of MR imaging and con-
ventional fluoroscopy for guidance,
we were able to successfully create a
percutaneous shunt and a vascular
anastomosis between the portal mes-
enteric venous system and the IVC.
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